Genomics

Dataset Information

0

Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34+ cell therapy to induce fetal hemoglobin for sickle cell disease [CHANGE-seq]

ABSTRACT: Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34+ cell therapy to induce fetal hemoglobin for sickle cell disease [CHANGE-seq]

PROVIDER: PRJNA1160904 | ENA |

REPOSITORIES: ENA

Json Xml

Dataset's files

Source:
Action DRS
SRR30664057_1.fastq.gz Fastqsanger.gz
SRR30664057_2.fastq.gz Fastqsanger.gz
SRR30664058_1.fastq.gz Fastqsanger.gz
SRR30664058_2.fastq.gz Fastqsanger.gz
SRR30664059_1.fastq.gz Fastqsanger.gz
Items per page:
1 - 5 of 24

Similar Datasets

Genomics Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34+ cell therapy to induce fetal hemoglobin for sickle cell disease
| PRJNA1149701 | ENA
Genomics Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34+ cell therapy to induce fetal hemoglobin for sickle cell disease
| PRJNA1160901 | ENA
Genomics Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34+ cell therapy to induce fetal hemoglobin for sickle cell disease [scRNA]
| PRJNA1149034 | ENA
Genomics Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34+ cell therapy to induce fetal hemoglobin for sickle cell disease [sgRNA]
| PRJNA1149703 | ENA
Transcriptomics Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34+ cell therapy to induce fetal hemoglobin for sickle cell disease
2024-08-21 | GSE275158 | GEO
Other Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34+ cell therapy to induce fetal hemoglobin for sickle cell disease
2024-09-14 | GSE277175 | GEO
Other Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34+ cell therapy to induce fetal hemoglobin for sickle cell disease [sgRNA]
2024-08-21 | GSE275157 | GEO
Transcriptomics Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34+ cell therapy to induce fetal hemoglobin for sickle cell disease [scRNA]
2024-08-21 | GSE275063 | GEO
Other Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34+ cell therapy to induce fetal hemoglobin for sickle cell disease [CHANGE-seq]
2024-09-14 | GSE277176 | GEO
Transcriptomics Comparison of IND induced vs. mock treated seedlings: Transcriptome profiling upon induction of the transcription factor IND
2011-05-12 | GSE28898 | GEO